As to US roll out post FDA approval I think this may be faster...

As to US roll out post FDA approval I think this may be faster than some expect due to the powerful prospective distribution partnerships already in place, but the gross margin pre such costs will be much lower than Australia, due to significant revenue share demands from them. So sadly the much larger market will, at least in part, be offset, by this higher cost. However, in my opinion, this is a worthwhile trade off, especially in view of the prohibitively high cost of setting up your own distribution and customer support in the US. Also, if a dollar in the hand against two in the bush reduces to some extent any equity based fund raising required to get the Company to a position where it can become self funding then I'm all for it.

Just my thoughts and certainly not investment advice to others.